Olga Popova

1. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
   2020/09/01 by Denis Y Logunov, Denis Y. Logunov, Inna V. Dolzhikova +59 · 2 voices · 4 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Neuroblastoma Research and Treatments #SARS-CoV-2 and COVID-19 Research #Virus-based gene therapy research
2. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
   2021/02/01 by Denis Y Logunov, Denis Y. Logunov, Inna V. Dolzhikova +57 · 8 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #SARS-CoV-2 and COVID-19 Research #Virus-based gene therapy research #vaccines and immunoinformatics approaches